ACL.AX ASX
Australian Clinical Labs Limited
1W: +0.7%
1M: +3.0%
3M: +22.4%
YTD: +11.2%
1Y: +6.9%
3Y: +3.7%
5Y: -21.2%
A$2.81 ($1.96)
+0.02 (+0.72%)
Weekly Expected Move ±3.4%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$593M
+3.1% ▲
5Y CAGR: +4.5%
Total Liabilities
$443M
+9.9% ▲
5Y CAGR: +2.4%
Shareholders Equity
$150M
-12.7% ▼
5Y CAGR: +12.8%
Cash & Investments
$26M
+16.0% ▲
5Y CAGR: -6.7%
Total Debt
$337M
+16.2% ▲
5Y CAGR: +2.8%
Net Debt
$313M
+16.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $26M | $20M | $26M | $21M | $25M |
| Short-Term Investments | $1M | $632K | $709K | $679K | $926K |
| Cash & ST Investments | $28M | $21M | $27M | $22M | $26M |
| Net Receivables | $91M | $75M | $81M | $70M | $67M |
| Inventory | $20M | $15M | $17M | $16M | $14M |
| Other Current Assets | $26K | $0 | $0 | $2M | $0 |
| Total Current Assets | $143M | $116M | $134M | $120M | $113M |
| Property, Plant & Equip. | $310M | $288M | $282M | $270M | $294M |
| Goodwill & Intangibles | $165M | $165M | $165M | $165M | $165M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $150K | $1M | $2M | $19M | $2M |
| Total Non-Current Assets | $485M | $463M | $459M | $455M | $480M |
| Total Assets | $628M | $579M | $593M | $575M | $593M |
| — Liabilities — | |||||
| Accounts Payable | $26M | $18M | $26M | $21M | $17M |
| Short-Term Debt | -$98M | $0 | $0 | $0 | $108M |
| Deferred Revenue | $92M | $69M | $0 | $0 | $0 |
| Other Current Liabilities | $25M | -$44M | $32M | $42M | $38M |
| Total Current Liabilities | $225M | $188M | $208M | $216M | $210M |
| Long-Term Debt | $0 | $66M | $55M | $42M | $62M |
| Other Non-Current Liab. | $3M | $3M | $3M | $5M | $4M |
| Total Non-Current Liabilities | $170M | $218M | $208M | $186M | $233M |
| Total Liabilities | $395M | $406M | $415M | $403M | $443M |
| — Equity — | |||||
| Common Stock | $793M | $792M | $792M | $781M | $759M |
| Retained Earnings | $216M | $155M | $159M | $34M | $166M |
| Accumulated OCI | -$777M | -$775M | -$773M | -$638M | -$770M |
| Total Stockholders Equity | $232M | $172M | $178M | $171M | $150M |
| Total Liabilities & Equity | $628M | $579M | $593M | $575M | $593M |
| — Key Metrics — | |||||
| Total Debt | $262M | $316M | $309M | $290M | $337M |
| Net Debt | $236M | $296M | $283M | $269M | $313M |
| Total Investments | $1M | $632K | $709K | $679K | $926K |